Acticam

RSS

meloxicam

Withdrawn
This medicine is now withdrawn from use in the European Union.

Overview

The marketing authorisation for Acticam has been withdrawn at the request of the marketing-authorisation holder.

This EPAR was last updated on 24/03/2021

Authorisation details

Product details
Name
Acticam
Agency product number
EMEA/V/C/000138
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
  • Dogs
  • Cats
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
GenericGeneric

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Publication details
Marketing-authorisation holder
Ecuphar
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
09/12/2008
Contact address
Legeweg 157-I
B-8020 Oostkamp
Belgium

Product information

22/03/2021 Acticam - EMEA/V/C/000138 - IAIN/0023

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Not yet assigned

Therapeutic indication

Oral suspension:

Dogs:

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

Solution for injection:

Dogs:

Alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.

Reduction of postoperative pain and inflammation following orthopaedic and soft-tissue surgery.

Cats:

Reduction of postoperative pain after ovariohysterectomy and minor soft-tissue surgery.

Assessment history

How useful was this page?

Add your rating